Psychotropic drug efficacy and side effects for persons with autism spectrum disorders

Research in Autism Spectrum Disorders

Volumn 5, Issue 1, 2011, Pages 230-236

  Matson, Johnny L ^a   Hess, Julie A ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

Autism; Psychotropic drugs; Side effects

Indexed keywords

PSYCHOTROPIC AGENT;

AUTISM; CLINICAL ASSESSMENT; COMORBIDITY; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; HEALTH CARE COST; HUMAN; IRRITABILITY; MEDICAL PRACTICE; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; SEDATION; SIDE EFFECT; TARDIVE DYSKINESIA; TREATMENT DURATION; WEIGHT GAIN;

EID: 77957350894     PISSN: 17509467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rasd.2010.04.004     Document Type: Article

References (94)

1. M. Alacqua, G. Trifiro, V. Arocraci, E. Germano, A. Magazu, and T. Calarese Use and tolerability of newer antipsychotics and antidepressants: A chart review in a pediatric setting Pharmacy World and Science 30 2008 44 50
2. M.G. Aman, C.A. Farmer, J. Holloway, and L.E. Arnold Treatment and inattention, overactivity and impulsiveness in autism spectrum disorders Child and Adolescent Psychiatric Clinics of North America 12 2008 23 45
3. M.G. Aman, K.S.L. Lam, and A. Collier-Crespin Prevalence and patterns of use of psychoactive medicines among individuals with autism in the autism society of Ohio Journal of Autism and Developmental Disorders 33 2003 527 534
4. M.G. Aman, and N.N. Singh Aberrant Behavior Checklist - New community version Journal of Child and Family Studies 3 1994 241
5. H. Appelgate, J.L. Matson, and K.E. Cherry An evaluation of functional variables affecting severe problem behavior in adults with mental retardation by using the Questions About Behavioral Function (QABF) Research in Developmental Disabilities 20 1999 229 237
6. S. Armand-Branger, N. Poisson, M. Gaudoneix-Taïeb, and O. Ramos Pharmaco-theraputic evaluation of medical treatments of adult autistics and multi-handicapped patients in a public mental health unit L'Encéphale 35 2009 370 376
7. C. Armstrong AAP releases guidelines on management of autism spectrum disorders Pediatrics 78 2008 1399 1404
8. A. Baghdadli, V. Gonnier, F. Valancogne, and C. Aussilloux Descriptive study of psychotropic use in the 20-35 age adults with autism in Languedoc-Roussillon L'Encephale 31 2005 302 308
9. J.R. Brasic, J.Y. Barnett, P. Aisemberg, S.C. Ahn, R.H. Nadrich, and D. Kaplan Dyskinesias subside off all medication in a boy with autistic disorder and severe mental retardation Psychological Reports 81 1997 755 767
10. J.L. Calles Jr. Use of psychotropic medication in children with developmental disabilities Pediatric Clinics of North America 55 2008 1227 1240
11. M. Campbell, J.L. Armenteros, R.P. Malone, P.B. Adams, M.A. Eisenberg, and J. Overall Neuroleptic-related dyskinesias in autistic children: A prospective, longitudinal study Journal of the American Academy of Child and Adolescent Psychiatry 36 1997 835 843
12. M. Campbell, E. Schopler, J.E. Cueva, and A. Hallin Treatment of autistic disorder Journal of the American Academy of Child and Adolescent Psychiatry 35 1996 134 143
13. H.M. Chiang Expressive communication of children with autism: The use of challenging behavior Journal of Intellectual Disability Research 52 2008 966 972
14. Cohen, I. L., Tsiouris, J. A., Flory, J. J., Kim, S. Y., Freedland, R., Heaney, G., et al. (in press). A large scale study of the psychometric characteristics of the IBR Modified Overt Aggression Scale: Findings and evidence for increased self-destructive behaviors in adults females with autism spectrum disorders. Journal of Autism and Developmental Disorders, doi:10.1007/s10803-009-0908-z.
15. P. Conrad Prescribing more psychotropic medication for children Archives of Pediatrics and Adolescent Medicine 158 2004 829 830
16. G.E. Crane, and R. Gardner Clinical psychopharmacology in its 20th year Science 181 1973 124
17. J.E. Dawson, J.L. Matson, and K.E. Cherry An analysis of maladaptive behaviors in persons with autism, PDD-NOS, and mental retardation Research in Developmental Disabilities 19 1998 439 448
18. S. Desjardins, C. Doyen, Y. Contejean, K. Kaye, and P. Paubel Treatment of a serious autistic disorder in a child with Naltrexone in an oral suspension form L'Encephale 35 2009 168 172
19. I. Durukan, A.E. Tufan, and T. Turkbay Risperidone treatment may benefit childhood disintegrative disorder: Presentation of two cases Bulletin of Clinical Psychopharmacology 19 2009 285 288
20. S. Eikeseth Outcome of comprehensive psycho-educational interventions for young children with autism Research in Developmental Disabilities 30 2009 158 178
21. C.R. Ellis, S.J. Carmanico, R.W. Ricketts, S. Chambers, and Y.N. Singh Reliability and validity of three rating scales for assessing tardive dyskinesia in individuals with developmental disabilities Journal of Developmental and Physical Disabilities 8 1996 391 406
22. C.A. Farmer, and M.G. Aman Development of the Children's Scale of Hostility and Aggression: Reactive/Proactive (C-SHARP) Research in Developmental Disabilities 30 2009 1155 1167
23. C. Feroz-Nainar, and M. Roy Risperidone and late onset tics Autism 10 2006 302 307
24. A. Fido, and S. Al-Saad Olanzapine in the treatment of behavioral problems associated with autism: An open-label trial in Kuwait Medical Principles and Practices 17 2008 415 418
25. R.L. Findling Pharmacologic treatment of behavioral symptoms in autism and pervasive developmental disorders Journal of Clinical Psychiatry 66 2005 26 29
26. M. Garcia, and J.L. Matson Akathesia in adults with severe and profound intellectual disability: A psychometric study with the MEDS and ARMS Journal of Intellectual and Developmental Disabilities 33 2008 171 176
27. D.L. Gilbert Drug-induced movement disorders in children Annals of the New York Academy of Sciences 1142 2008 72 84
28. Guy, W. (1976). ECDEU assessment manual for psychopharmacology (DHEW publication no [ADM] 76-338). Rockville, MD: National Institute of Mental Health.
29. S.L. Hartley, D.M. Sikora, and R. McCoy Prevalence and risk factors of maladaptive behaviour in young children with autistic disorder Journal of Intellectual Disability Research 52 2008 819 829
30. M. Hasnain, W.V.R. Vieweg, J.M. Hettema, D. Colton, A. Fernandez, and A.K. Pandurangi The risk of overweight in children and adolescents with major mental illness Southern Medical Journal 101 2008 367 372
31. J.A. Hellings, J.R. Zarcone, K. Crandall, D. Wallace, and S.R. Schroeder Weight gained in a controlled study of Risperidone in children, adolescents, and adults with mental retardation and autism Journal of Child and Adolescent Psychiatry 11 2001 229 238
32. J.R. Hughes Update on autism: A review of 1300 reports published in 2008 Epilepsy and Behavior 16 2009 569 589
33. J.M. Jerrell, T.-L. Hwang, and T.S. Livingston Neurological adverse events associated with antipsychotic treatment in children and adolescents Journal of Child Neurology 23 2008 1392 1399
34. J.M. Jerrell, and R.S. McIntyre Adverse events in children and adolescents treated with antipsychotic medications Human Psychopharmacology 23 2008 283 290
35. A. Kolevzon, K.A. Mathewson, and E. Hollander Selective serotonin reuptake inhibitors in autism: A review of efficacy and tolerability Journal of Clinical Psychiatry 67 2006 407 414
36. H. Kwon Tardive dyskinesia in an autistic patient: Treatment with Risperidone American Journal of Psychiatry 161 2004 757 758
37. S.E. Lakhan, and G.E. Hagger-Johnson The impact of prescribing psychotropics on youth Clinical Practice and Epidemiology in Mental Health 3 2007 21
38. K.S. Langworthy-Lam, M.G. Aman, and M.E. Van Bourgondien Prevalence and patterns of use of psychoactive medicines in individuals with autism in the Autism Society of North American Journal of Child and Adolescent Psychopharmacology 12 2002 311 321
39. T.J. Leskovec, B.M. Rowles, and R. Findling Pharmacological treatment options for autism spectrum disorders in children and adolescents Harvard Review of Psychiatry 16 2008 97 112
40. R.P. Malone, G. Maislin, M.S. Choudhury, C. Gifford, and M.A. Delaney Risperidone treatment in children and adolescents with autism: Short and long term safety and effectiveness Journal of the American Academy of Child and Adolescent Psychiatry 41 2002 140 147
41. R.P. Malone, and A. Waheed The role of antipsychotics in the management of behavioural symptoms in children and adolescents with autism Drugs 69 2009 535 548
42. J.L. Matson Determining treatment outcome in early intervention programs for autism spectrum disorders: A critical analysis of measurement issues in learning based interventions Research in Developmental Disabilities 28 2007 207 218
43. J.L. Matson Current status of differential diagnosis for children with autism spectrum disorders Research in Developmental Disabilities 28 2007 109 118
44. J.L. Matson, C.S. Baglio, B.B. Smiroldo, M. Hamilton, Packlowskyj, and D. Williams Characteristics of autism as assessed by the Diagnostic Assessment for the Severely Handicapped-II (DASH-II) Research in Developmental Disabilities 17 1996 135 143
45. J.L. Matson, and J.W. Bamburg Reliability of the assessment of dual diagnosis (ADD) Research in Developmental Disabilities 18 1998 221 225
46. J.L. Matson, J.W. Bamburg, K.E. Cherry, and T.R. Paclawskyj A validity study on the Questions About Behavioral Function (QABF) scale: Predicting treatment success for self-injury, aggression, and stereotypies Research in Developmental Disabilities 20 1999 229 237
47. J.L. Matson, and J.A. Boisjoli Differential diagnosis of PDDNOS in children Research in Autism Spectrum Disorders 1 2007 75 84
48. J.L. Matson, and J.A. Boisjoli The token economy for children with intellectual disability and/or autism: A review Research in Developmental Disabilities 30 2009 240 248
49. J.L. Matson, and J.A. Boisjoli An overview of developments in research on persons with intellectual disabilities Research in Developmental Disabilities 30 2009 240 248
50. J.L. Matson, C.B. Carlisle, and J.W. Bamburg The convergent validity of the Matson Evaluation of Social Skills for individuals with sEvere Retardation (MESSIER) Research in Developmental Disabilities 19 1998 493 500
51. J.L. Matson, T. Dempsey, S.V. LoVullo, and J. Wilkins The effects of intellectual functioning on the range of core symptoms on autism spectrum disorders Research in Developmental Disabilities 29 2008 341 350
52. J.L. Matson, J.C. Fodstad, and J.A. Boisjoli Cutoff scores, norms, and patterns of feeding problems for the Screening Tool of fEeding Problems (STEP) for adults with intellectual disabilities Research in Developmental Disabilities 29 2008 363 372
53. J.L. Matson, S. Mahan, and S.V. LoVullo Parent training: A review of methods for children with developmental disabilities Research in Developmental Disabilities 30 2009 961 968
54. J.L. Matson, and D. Neal Psychotropic medication use for challenging behaviors in persons with intellectual disabilities: An overview Research in Developmental Disabilities 30 2009 572 586
55. J.L. Matson, and M. Nebel-Schwalm Assessing challenging behaviors in children with autism spectrum disorders: A review Research in Developmental Disabilities 28 2007 567 579
56. J.L. Matson, and M.S. Nebel-Schwalm Comorbid psychopathology with autism spectrum disorders in children: An overview Research in Developmental Disabilities 28 2007 341 352
57. J.L. Matson, and M. Shoemaker Intellectual disability and its relationship to autism spectrum disorders Research in Developmental Disabilities 30 2009 1107 1114
58. J.L. Matson, and B.B. Smiroldo Validity of the mania subscale of the DASH-II Research in Developmental Disabilities 18 1997 221 226
59. J.L. Matson, B.B. Smiroldo, and J.W. Bamburg The relationship of social skills to psychopathology for individuals with severe or profound mental retardation Journal of Intellectual and Developmental Disability 23 1998 137 145
60. J.L. Matson, and J. Wilkins Psychometric testing methods for children's social skills Research in Developmental Disabilities 30 2009 249 274
61. M.L. Mattila, M. Kielinen, K. Jussila, S.L. Linna, R. Bloigu, and H. Ebeling An epidemiological and diagnostic study of Asperger syndrome according to four sets of diagnostic criteria Nascer e Crecer 17 2008 85 86
62. J.T. McCracken, J. McGough, B. Shah, P. Cronin, D. Hong, and M.G. Aman Risperidone in children with autism and serious behavioral problems The New England Journal of Medicine 347 2002 314 321
63. C.J. McDougle, K.A. Stiger, C.A. Erickson, and D.J. Posey Pharmacology of autism Clinical Neuroscience Research 6 2006 179 188
64. H. Meltzer Atypical antipsychotic drugs have their merits The Lancet 373 2009 1007
65. M.R. Mohammadi, and S. Akhondzadeh Autism spectrum disorders: Etiology and pharmacotherapy Current Drug Therapy 2 2007 97 103
66. S.M. Myers The status of pharmacotherapy for autism spectrum disorders Expert Opinion on Pharmacotherapy 8 2007 1579 1603
67. R. Nagaraj, P. Singhi, and P. Malhi Risperidone in children with autism: Randomized, placebo-controlled, double-blind study Journal of Clinical Neurology 21 2006 450 455
68. P. Oliver-Africano, S. Dickens, Z. Ahmed, N. Bouras, S. Cooray, and S. Deb Overcoming the barriers experienced in conducting a medication trial in adults with aggressive challenging behaviour and intellectual disabilities Journal of Intellectual Disability Research 54 2010 17 25
69. P. Oliver-Africano, D. Murphy, and P. Tyrer Aggressive behaviour in adults with intellectual disability defining the role of drug treatment CNS DRUGS 23 2009 903 913
70. M.S. Parikh, A. Kolevzon, and E. Hollander Psychopharmacology of aggression in children and adolescents with autism: A critical review of efficacy and tolerability Journal of Childhood and Adolescent Pharmacology 18 2008 157 178
71. G.W. Paulson, C.A. Rizvi, and G.E. Crane Tardive dyskinesia as a possible sequel of long-term therapy with phenothiazines Clinical Pediatrics 14 1975 955 963
72. R. Perry, C. Pataki, D.M. Munoz-Silva, J. Armenteros, and R.R. Silva Risperidone in children and adolescents with pervasive developmental disorder: Pilot trial and follow-up Journal of Child and Adolescent Psychopharmacology 7 1997 167 179
73. E.S. Petscher, C. Rey, and J.S. Bailey A review of empirical support for differential reinforcement of alternative behaviors Research in Developmental Disabilities 30 2009 409 425
74. D.J. Posey, K.A. Stigler, C.A. Erickson, and C.J. McDougle Antipsychotics in the treatment of autism The Journal of Clinical Investigation 118 2008 6 14
75. L. Poustka, and F. Poustka Psychopharmakologie autistischer st□rugen Zeitschrift für Kinder-und Jugend Psychiatrie and Psychotherapie 35 2007 87 94
76. G. Provenzano, and G. Mantia Psychopharmacology in pre-school and school-age children Acta Medica Mediterranea 24 2008 109 112
77. P.J. Santosh, and G. Baird Pharmacotherapy of target symptoms in autistic spectrum disorders Indian Journal of Pediatrics 68 2001 427 431
78. P.J. Santosh, and R. Suren Paediatric psychopharmacology special considerations Psychiatry 7 2008 384 388
79. B.L. Schlaggar, and J.W. Mink Movement disorders in children Pediatrics in Review 24 2003 39 51
80. L.J. Scott, and S. Dhillon Risperidone: A review of its use in the treatment of irritability associated with autism disorder in children and adolescents Pediatric Drugs 9 2007 343 354
81. P.L. Shattuck The contribution of diagnostic substitution to the growing administrating prevalence of autism in US special educations Pediatrics 117 2006 1028 1037
82. L. Shin, H. Bregman, J. Frazier, and N. Noyes An overview of obesity in children with psychiatric disorders taking atypical antipsychotics Harvard Review of Psychiatry 16 2008 69 79
83. G.M. Simpson, and J.W. Angus A rating scale for extrapyramidal side effects Acta Psychiatrica Scandinavia Supplement 212 1970 11 19
84. L. Soorya, J. Kiarashi, and E. Hollander Psychopharmacologic interventions for repetitive behaviors in autism spectrum disorders Child and Adolescent Psychiatric Clinics of North America 17 2008 753 771
85. J.A. Sparks, and B.L. Duncan Do no harm: A critical risk/benefit analysis of child psychotropic medication Journal of Family Psychotherapy 19 2008 1 19
86. J.M. Stachnik, and C. Nunn-Thompson Use of atypical antipsychotic in the treatment of autistic disorder The Annals of Pharmacotherapy 41 2007 626 634
87. K.A. Stigler, and C.J. McDougle Pharmacotherapy of irritability in pervasive developmental disorders Child and Adolescent Psychiatric Clinics of North America 17 2008 739 752
88. K.A. Stigler, M.N. Potenza, D.J. Posey, and C.J. McDougle Weight gain associated with atypical antipsychotic use in children and adolescents: Prevalence, clinical relevance, and management Pediatric Drugs 6 2004 33 44
89. K.E. Towbin Strategies for pharmacologic treatment of high functioning autism and Asperger syndrome Child and Adolescent Psychiatric Clinics of North America 12 2003 23 45
90. P. Tyrer, and T. Kendall The spurious advance of antipsychotic drug therapy The Lancet 373 2009 4 5
91. P. Tyrer, P. Oliver-Africano, R. Romeo, M. Knapp, S. Dickens, and N. Bouras Neuroleptics in the treatment of aggressive challenging behaviour for people with intellectual disabilities: A randomized controlled trial (NACHBID) Health Technology Assessment 13 2009 1 54
92. F. Volkmar, E.H. Cook Jr., J. Pomeroy, G. Realmuto, and P. Tanguay Practice parameters for the assessment and treatment of children, adolescents, and adults with autism and other pervasive developmental disorders Journal of the American Academy of Child and Adolescent Psychiatry 38 1999 32S 54S
93. T. Wisniewski, M.B. Brimacombe, and X. Ming Pharmaceutical treatment studies in: A design based review of study quality Journal of Pediatric Neurology 5 2007 189 197
94. A. Witwer, and L. Lecavalier Treatment incidence and patterns in children and adolescents with autism spectrum disorders Journal of Child and Adolescent Psychopharmacology 15 2005 671 681